Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Eloralintide (CAS No: 2883634-40-8) is a cutting-edge peptide for diabetes and obesity research
GLP-1 RAs, initially developed for type 2 diabetes (T2D) and obesity, have emerged as promising candidates for treating addiction
This system is designed for the co-delivery of cepharanthine and selenium
Coggon D, Reading I, Croft P, McLaren M, Barrett D, Cooper C (2001) Knee osteoarthritis and obesity
Additionally, hypoxia stimulates the expression of lipid transport proteins, such as CD36 and FABP3, facilitating the increased uptake of extracellular fatty acids which aids in tumor proliferation
US$ 29.62
US$ 26.80
US$ 23.01
US$ 28.31
US$ 29.13
US$ 22.86
US$ 22.74
US$ 20.31
US$ 20.92
US$ 23.64
